Lakefront Biotherapeutics | GLPG - Capitale Ordinario





Capitale Ordinario Cambiamento Data
argenx SE USD 62.54M 2.74M 2026-06
AstraZeneca USD 1.55B 44K 2026-06
Biogen USD 146.7M 200K 2025-09
Genmab DKK 61.44M 181K 2026-06
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
GRIFOLS EUR 680.58M 6K 2026-06
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Incyte USD 200.98M 1.03M 2026-06
Merck EUR 434.78M 0 2026-06
Neurocrine Biosciences USD 100.55M 50K 2026-06
Novartis USD 1.9B 7.38M 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.21B 8.25M 2026-03
UCB EUR 190.36M 365.15K 2025-12
Vertex Pharmaceuticals USD 253.3M 900K 2026-06